Format

Send to

Choose Destination
J Cardiovasc Thorac Res. 2016;8(1):40-2. doi: 10.15171/jcvtr.2016.07. Epub 2016 Mar 15.

Device closure in adults with atrial septal defect in Shiraz, a single center registry.

Author information

1
Cardiovascular Research Center, Cardiology Department, Shiraz University of Medical Sciences, Shiraz, Iran.
2
Master of Management, School of Management and Information, Shiraz University of Medical Sciences, Shiraz, Iran.

Abstract

INTRODUCTION:

Successful closure of atrial septal defect (ASD) improves patients' functional class and exercise capacity. In this study we evaluate the safety and feasibility of percutaneous device closure of ASDs.

METHODS:

Two hundred fifty six patients with significant ASD according to our criteria were enrolled. The patients were treated using nitinol wire mesh transcatheter devices. Complications were followed for a median of 2.5 years.

RESULTS:

Success rate was 98.4% with 3 unsuccessful cases and a mean hospital stay of 1.007 ± 0.0004 days. Complication rate was 7.42%. Size of the right ventricle (RV) annulus was significantly decreased 24 hours after intervention (P = 0.005).

CONCLUSION:

The present report demonstrates that transcatheter closure of ASD is safe and effective.

KEYWORDS:

ASD Devices; Atrial Septal Defect; Complications; Surgical Closure; Transcatheter Closure

Supplemental Content

Full text links

Icon for PubMed Central
Loading ...
Support Center